{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_structure_properties_text in Structure Properties (approximate match)
Status:
Possibly Marketed Outside US
Source:
Super Joint Forte by Novel Pack LLC
(2022)
Source URL:
First approved in 2022
Source:
Super Joint Forte by Novel Pack LLC
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2010)
Source URL:
First approved in 2010
Source:
21 CFR 352
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
Prenatvite by SLV PHARMACEUTICALS LLC DBA AUM PHARMACEUTICALS
Source URL:
First approved in 2009
Source:
Calcium Folic Acid Plus D Chewable by Acella Pharmaceuticals, LLC
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Boron gluconate is a boron-containing dietary supplement. Calcium salt of boron gluconate is used as a calcium supplement in veterinary to treat hypocalcemia (also called parturient paresis and commonly called milk fever) in cattle, sheep, and goat.
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2004)
Source URL:
First approved in 2004
Source:
21 CFR 348
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
US Approved Rx
(1996)
Source:
NDA020372
(1996)
Source URL:
First approved in 1973
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Status:
US Approved Rx
(1996)
Source:
NDA020372
(1996)
Source URL:
First approved in 1973
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Status:
Investigational
Source:
NCT02907073: Phase 1/Phase 2 Interventional Terminated Myeloma
(2016)
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Investigational
Source:
NCT00114790: Phase 1/Phase 2 Interventional Completed Head and Neck Cancer
(2003)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Sodium fluoroborate (sodium tetrafluoroborate) is an inorganic compound with the formula NaBF4. It is used in the sand casting of aluminum, electrochemical processes, and as fluorinating agent. It is also used as an additive in chrome, nickel and cadmium plating baths. Sodium tetrafluoroborate may be used as a catalyst for the synthesis of bis(indolyl)methanes via electrophilic substitution reaction of indoles with aldehydes and ketones. It may also be used as a source of tetrafluoroborate anoins during the synthesis of ionic liquids like 1-butyl-3-methylimidazolium tetrafluoroborate[4] and trihexyl(tetradecyl)phosphonium tetrafluoroborate.
